SCHEMBL2225639

SCHEMBL2225639

NS(=O)(=O)c1cccc(CNc2cc(Nc3ccc4c(c3)OCCO4)ncn2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.44
ERBB3 P21860 1/20 0.44
RHOA P61586 1/20 0.43
TRPV1 Q8NER1 2/20 0.42
BACE1 P56817 1/20 0.42
JAK3 P52333 3/20 0.42
JAK2 O60674 2/20 0.42
JAK1 P23458 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNA2 P20248 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
GAA P10253 1/20 0.41
TNNI3K Q59H18 2/20 0.41
CCNT1 O60563 1/20 0.41
CDK9 P50750 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2226929 0.94 ALDH1A1 (0.48) EGFRERBB3JAK3ALDH1A1CDK1
SCHEMBL2225797 0.81 EGFR (0.44) EGFRERBB3JAK3JAK2JAK1
SCHEMBL2224438 0.81 TNNI3K (0.57) EGFRERBB3JAK3TNNI3KCCNT1
SCHEMBL2225416 0.81 NTRK1 (0.56) EGFRERBB3JAK3CDK2TNNI3K
SCHEMBL2226138 0.81 TNNI3K (0.57) EGFRERBB3JAK3CDK1TNNI3K
SCHEMBL2225385 0.81 CDK1 (0.43) EGFRERBB3RHOATRPV1BACE1
SCHEMBL2224478 0.80 NTRK1 (0.47) EGFRERBB3JAK3JAK2JAK1
SCHEMBL2228327 0.80 CYP1A2 (0.52) EGFRERBB3JAK3ALDH1A1TNNI3K
SCHEMBL2225022 0.78 KDR (0.46) EGFRERBB3JAK3CDK1CCNB1
SCHEMBL2225667 0.78 JAK1 (0.47) EGFRERBB3JAK3JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed